125 related articles for article (PubMed ID: 36373989)
1. A Flow Cytometry-Based Assay to Measure C3b Deposition on Protozoan Parasites Such as Toxoplasma gondii.
Sikorski PM; Grigg ME
Curr Protoc; 2022 Nov; 2(11):e593. PubMed ID: 36373989
[TBL] [Abstract][Full Text] [Related]
2.
Sikorski PM; Commodaro AG; Grigg ME
Front Immunol; 2019; 10():3105. PubMed ID: 32010145
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
Schenkman S; Güther ML; Yoshida N
J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
Sturtevant JE; Balber AE
Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
[TBL] [Abstract][Full Text] [Related]
5. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii: mechanism of resistance to complement-mediated killing.
Fuhrman SA; Joiner KA
J Immunol; 1989 Feb; 142(3):940-7. PubMed ID: 2643665
[TBL] [Abstract][Full Text] [Related]
7. A Protective and Pathogenic Role for Complement During Acute
Sikorski PM; Commodaro AG; Grigg ME
Front Cell Infect Microbiol; 2021; 11():634610. PubMed ID: 33692968
[TBL] [Abstract][Full Text] [Related]
8. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential.
Kushihata F; Watanabe J; Mulder A; Claas F; Scornik JC
Transplantation; 2004 Oct; 78(7):995-1001. PubMed ID: 15480164
[TBL] [Abstract][Full Text] [Related]
10. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement.
Tomlinson S; Pontes de Carvalho LC; Vandekerckhove F; Nussenzweig V
J Immunol; 1994 Oct; 153(7):3141-7. PubMed ID: 8089492
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
12. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Oct; 131(4):1930-5. PubMed ID: 6225800
[TBL] [Abstract][Full Text] [Related]
13. The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces.
Chen CC; Borden MA
Biomaterials; 2011 Sep; 32(27):6579-87. PubMed ID: 21683439
[TBL] [Abstract][Full Text] [Related]
14. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.
Clay CD; Soni S; Gunn JS; Schlesinger LS
J Immunol; 2008 Oct; 181(8):5568-78. PubMed ID: 18832715
[TBL] [Abstract][Full Text] [Related]
15. Opsonization of yeast cells with equine iC3b, C3b, and IgG.
Gröndahl G; Johannisson A; Jensen-Waern M; Nilsson Ekdahl K
Vet Immunol Immunopathol; 2001 Aug; 80(3-4):209-23. PubMed ID: 11457475
[TBL] [Abstract][Full Text] [Related]
16. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
Sher A; Hieny S; Joiner K
J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
[TBL] [Abstract][Full Text] [Related]
17. Not a Simple Tether: Binding of Toxoplasma gondii AMA1 to RON2 during Invasion Protects AMA1 from Rhomboid-Mediated Cleavage and Leads to Dephosphorylation of Its Cytosolic Tail.
Krishnamurthy S; Deng B; Del Rio R; Buchholz KR; Treeck M; Urban S; Boothroyd J; Lam YW; Ward GE
mBio; 2016 Sep; 7(5):. PubMed ID: 27624124
[TBL] [Abstract][Full Text] [Related]
18. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
Norris KA
Microb Pathog; 1996 Oct; 21(4):235-48. PubMed ID: 8905613
[TBL] [Abstract][Full Text] [Related]
19. Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.
Albertí S; Alvarez D; Merino S; Casado MT; Vivanco F; Tomás JM; Benedí VJ
Infect Immun; 1996 Nov; 64(11):4726-32. PubMed ID: 8890232
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Characterization of
Fu Y; Cui X; Fan S; Liu J; Zhang X; Wu Y; Liu Q
mBio; 2018 Oct; 9(5):. PubMed ID: 30352931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
